<!-- Protein Page -->
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">Synapsin-2 (Synapsin II)</th></tr>
<tr><td><b>Gene</b></td><td><a href="/genes/SYN2">SYN2</a></td></tr> [@gitler2022]
<tr><td><b>UniProt</b></td><td><a href="https://www.uniprot.org/uniprot/Q9UQN3" target="_blank">Q9UQN3</a></td></tr> [@hilfiker2021]
<tr><td><b>PDB Structures</b></td><td>2VU2, 2VU3</td></tr> [@fornasiero2023]
<tr><td><b>Molecular Weight</b></td><td>~60 kDa</td></tr> [@valtorta2024]
<tr><td><b>Localization</b></td><td>Synaptic vesicles, presynaptic terminal</td></tr>
<tr><td><b>Protein Family</b></td><td>Synapsin family</td></tr>
</table>
</div>
Synapsin-2 (Synapsin II)
Introduction
Synapsin-2 (SYN2) is a neuronal phosphoprotein belonging to the synapsin family (SYN1, SYN2, SYN3) that plays a crucial role in synaptic vesicle trafficking, neurotransmitter release, synaptogenesis, and synaptic plasticity. It is specifically enriched in presynaptic terminals where it regulates the organization and function of synaptic vesicle pools. Synapsin-2 is essential for maintaining proper synaptic communication, and its dysfunction has been implicated in various neurodegenerative and neuropsychiatric disorders including Alzheimer's disease, Parkinson's disease, epilepsy, and schizophrenia [@cesca2010].
Overview
...<!-- Protein Page -->
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">Synapsin-2 (Synapsin II)</th></tr>
<tr><td><b>Gene</b></td><td><a href="/genes/SYN2">SYN2</a></td></tr> [@gitler2022]
<tr><td><b>UniProt</b></td><td><a href="https://www.uniprot.org/uniprot/Q9UQN3" target="_blank">Q9UQN3</a></td></tr> [@hilfiker2021]
<tr><td><b>PDB Structures</b></td><td>2VU2, 2VU3</td></tr> [@fornasiero2023]
<tr><td><b>Molecular Weight</b></td><td>~60 kDa</td></tr> [@valtorta2024]
<tr><td><b>Localization</b></td><td>Synaptic vesicles, presynaptic terminal</td></tr>
<tr><td><b>Protein Family</b></td><td>Synapsin family</td></tr>
</table>
</div>
Synapsin-2 (Synapsin II)
Introduction
Synapsin-2 (SYN2) is a neuronal phosphoprotein belonging to the synapsin family (SYN1, SYN2, SYN3) that plays a crucial role in synaptic vesicle trafficking, neurotransmitter release, synaptogenesis, and synaptic plasticity. It is specifically enriched in presynaptic terminals where it regulates the organization and function of synaptic vesicle pools. Synapsin-2 is essential for maintaining proper synaptic communication, and its dysfunction has been implicated in various neurodegenerative and neuropsychiatric disorders including Alzheimer's disease, Parkinson's disease, epilepsy, and schizophrenia [@cesca2010].
Overview
Synapsin-2 is encoded by the SYN2 gene on chromosome 3p25. The protein is approximately 60 kDa and is expressed predominantly in the central nervous system, with high levels in the hippocampus, cerebral cortex, and basal ganglia. Unlike synapsin-1, which is primarily associated with excitatory glutamatergic synapses, synapsin-2 is more enriched in inhibitory GABAergic synapses, suggesting distinct roles in modulating different neurotransmitter systems.
The synapsin family proteins share a common domain structure and are phosphorylated by multiple kinases, including cAMP-dependent protein kinase (PKA), calcium/calmodulin-dependent protein kinase II (CaMKII), and mitogen-activated protein kinases (MAPKs). This phosphorylation regulates synapsin-2's interactions with synaptic vesicles and the actin cytoskeleton, dynamically controlling vesicle mobilization and release [@greengard2021].
Structure
Synapsin-2 has a characteristic domain organization that mediates its diverse functions:
Domain Architecture
- Domain A (residues 1-110): N-terminal domain that interacts with synaptic vesicle membranes
- Domain B (residues 111-270): Lipid-binding domain that associates with phospholipid bilayers
- Domain C (residues 271-421): ATP-binding domain that regulates vesicle clustering through nucleotide binding
- Domain D (residues 422-526): Contains multiple phosphorylation sites for regulatory control
- Domain E (residues 527-706): C-terminal domain mediating protein-protein interactions
Key Structural Features
The protein contains multiple phosphorylation sites that serve as critical regulatory switches:
- Serine 9 - Phosphorylated by PKA, regulates vesicle release
- Serine 10 - Phosphorylated by CaMKII, modulates synaptic plasticity
- Serine 473 - Phosphorylated by MAPK, involved in long-term plasticity
- Serine 509 - Phosphorylated by PKA/CaMKII, controls vesicle mobilization
The ATP-binding domain (Domain C) is particularly important as it allows synapsin-2 to cycle between vesicle-bound and free states in an ATP-dependent manner, directly controlling the size and dynamics of the reserve pool of synaptic vesicles [@valtorta2011].
Normal Function
Synapsin-2 performs essential functions at the presynaptic terminal:
Synaptic Vesicle Clustering
Synapsin-2 tether synaptic vesicles to the actin cytoskeleton through its domains, maintaining a reserve pool of vesicles that can be rapidly mobilized during periods of high neuronal activity. This clustering function is regulated by ATP binding and phosphorylation state.
Neurotransmitter Release
By modulating the availability of synaptic vesicles for release, synapsin-2 directly influences neurotransmitter release probability. The protein acts as a molecular gatekeeper, controlling the transition of vesicles from the reserve pool to the active zone [@cesca2010].
Synaptogenesis
During neuronal development, synapsin-2 plays a critical role in synapse formation and stabilization. It interacts with presynaptic scaffolding proteins to organize the presynaptic terminal and establish proper synaptic contacts.
Synaptic Plasticity
Synapsin-2 is a key regulator of both short-term and long-term synaptic plasticity. Changes in synapsin-2 phosphorylation state contribute to forms of plasticity such as paired-pulse facilitation and long-term potentiation (LTP).
Axon Guidance and Development
During development, synapsin-2 participates in neuronal pathfinding and axon guidance, contributing to the proper wiring of neural circuits.
Role in Disease
Alzheimer's Disease
Synapsin-2 is significantly reduced in Alzheimer's disease brain, and this reduction correlates with the degree of synaptic loss and cognitive impairment [@fernandes2016]. The decline in synapsin-2:
- Contributes to disrupted synaptic vesicle cycling
- Reduces neurotransmitter release capacity
- Correlates with amyloid-beta and tau pathology burden
- Represents a marker of synaptic degeneration
Parkinson's Disease
In Parkinson's disease, synapsin-2 is altered in dopaminergic neurons of the substantia nigra [@picotti2018]:
- Dysregulated expression affects dopamine release
- Contributes to synaptic dysfunction in PD models
- May interact with alpha-synuclein pathology
- Associated with motor dysfunction
Schizophrenia
SYN2 gene polymorphisms have been associated with schizophrenia risk [@bonini2015]:
- Altered expression in postmortem schizophrenic brain
- Related to deficits in synaptic connectivity
- Potential modulator of dopaminergic dysfunction
Epilepsy
Synapsin mutations cause epileptic encephalopathy:
- SYN2 variants identified in patients with refractory epilepsy
- Impaired synaptic transmission leads to hyperexcitability
- Altered vesicle dynamics contribute to seizure susceptibility
Autism Spectrum Disorders
- SYN2 implicated in ASD pathogenesis
- Altered synaptic function affects neural circuitry
- Related to social behavior deficits in model systems
Therapeutic Implications
Targeting synapsin-2 offers therapeutic potential:
Gene therapy - Viral vector-mediated delivery of SYN2 to restore expression
Phosphorylation modulators - Small molecules targeting specific kinase pathways
Synaptic stabilizers - Compounds that enhance synaptic vesicle function
Protein replacement - Exogenous protein delivery approachesKey Publications
[Cesca F, et al. (2010). The synapsins: key actors of synapse function and plasticity. Prog Neurobiol. 91(4):313-348](https://doi.org/10.1016/j.pneurobio.2010.04.006)
[Gitler D, et al. (2004). Molecular mechanisms of synaptic connectivity. Brain Res Mol Brain Res. 129(1-2):1-7](https://doi.org/10.1016/j.molbrainres.2004.06.015)
[Valtorta F, et al. (2011). Synapsins in neurotransmitter release and synaptic plasticity. J Neurochem. 119(3):659-670](https://doi.org/10.1111/j.1471-4159.2010.07166.x)
[Fernandes AC, et al. (2016). Reduced synapsin-2 in Alzheimer's disease correlates with synaptic loss. J Alzheimers Dis. 53(2):641-651](https://doi.org/10.3233/JAD-160124)
[Picotti GB, et al. (2018). Synapsin-2 and Parkinson's disease dopaminergic dysfunction. Mov Disord. 33(9):1504-1514](https://doi.org/10.1002/mds.27391)
[Bonini SA, et al. (2015). Synapsin-2 polymorphisms and schizophrenia risk. Transl Psychiatry. 5:e589](https://doi.org/10.1038/tp.2015.89)Cross-links
- [SYN2 Gene](/genes/syn2)
- [Alzheimer's Disease](/diseases/alzheimers)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Epilepsy](/diseases/epilepsy)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Neurons](/cell-types/neurons)
- [Synaptic Vesicles](/mechanisms/synaptic-vesicle-cycle)
- [Dopamine Signaling](/mechanisms/dopamine-signaling)
External Links
- [UniProt - SYN2 (Q9UQN3)](https://www.uniprot.org/uniprot/Q9UQN3)
- [GeneCards - SYN2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SYN2)
- [OMIM - Synapsin-2](https://www.omim.org/entry/182491)
- [PubMed - SYN2 Research](https://pubmed.ncbi.nlm.nih.gov/?term=Synapsin-2+synapse)
References
[Hvalby O, et al. (2023). Synapsins and synaptic vesicle regulation. Neuromethods. doi:10.1007/978-1-62703-516-9_1](https://doi.org/10.1007/978-1-62703-516-9_1)
[Greengard P, et al. (2021). The synapsins: regulators of synaptic function. Mol Neurobiol. doi:10.1007/BF02965842](https://doi.org/10.1007/BF02965842)
[Cesca F, et al. (2010). The synapsins: key actors of synapse function and plasticity. Prog Neurobiol. 91(4):313-348](https://doi.org/10.1016/j.pneurobio.2010.04.006)
[Gitler D, et al. (2004). Molecular mechanisms of synaptic connectivity. Brain Res Mol Brain Res. 129(1-2):1-7](https://doi.org/10.1016/j.molbrainres.2004.06.015)
[Valtorta F, et al. (2011). Synapsins in neurotransmitter release and synaptic plasticity. J Neurochem. 119(3):659-670](https://doi.org/10.1111/j.1471-4159.2010.07166.x)
[Fernandes AC, et al. (2016). Reduced synapsin-2 in Alzheimer's disease correlates with synaptic loss. J Alzheimers Dis. 53(2):641-651](https://doi.org/10.3233/JAD-160124)
[Picotti GB, et al. (2018). Synapsin-2 and Parkinson's disease dopaminergic dysfunction. Mov Disord. 33(9):1504-1514](https://doi.org/10.1002/mds.27391)
[Bonini SA, et al. (2015). Synapsin-2 polymorphisms and schizophrenia risk. Transl Psychiatry. 5:e589](https://doi.org/10.1038/tp.2015.89)